Novel Phage Therapy Saves Patient with Multidrug-Resistant Bacterial Infection

Intravenous viruses are used to target deadly bacterium; dramatic case suggests potential alternative to failing antibiotics —

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center – Biological Defense Research Directorate (NMRC-BDRD), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages — viruses that target and consume specific strains of bacteria — to treat a patient near death from a multidrug-resistant bacterium. … Read the Full Story from the UC San Diego Health Newsroom